Marex Group (Nasdaq: MRX) just guided Q1 2026 revenue to $667–$697M — a 43–49% jump from Q1 2025 — and the stock is still trading at 11x trailing earnings. TD Cowen raised its target to $66 on March 27. At $43.50, that’s 52% upside from current levels. The business has grown profit for 11 consecutive years. Most retail investors have never heard of it.
There’s a reason MRX doesn’t show up on Reddit or Fintwit: it’s not exciting. No AI pivot, no celebrity CEO, no moonshot product. Marex is a financial services platform — it provides liquidity, execution, and clearing infrastructure for commodity and financial markets. It makes money when clients trade. When energy prices whipsaw, when metals spike on supply disruptions, when agricultural commodities reprice around geopolitical chaos — Marex collects on every transaction. The Iran war has been very good for business.
The Numbers That Matter
FY 2025 full-year results (reported March 3, 2026):
- Revenue: $2,024.1M (+27% year-over-year)
- Adjusted Profit Before Tax: $418.1M (+30%)
- Basic EPS: $4.12 (+39%)
- Adjusted PBT margin: 20.7% (expanded from 20.1% in FY 2024)
Q4 2025 was the best quarter in company history:
- Revenue: $572.1M (+38% YoY), beat estimates by 8.76%
- Adjusted PBT: $114.9M (+41%)
- EPS: $1.12 — beat the $1.02 consensus by 10.2%
That’s four consecutive quarters of beating EPS estimates. Q1 2026 guidance from the March 26 Investor Day: $667M–$697M revenue and $140M–$150M adjusted PBT. At the midpoint, revenue is up 46% from Q1 2025’s $467M. Profit before tax is up 56% from Q1 2025’s $96M.
Current valuation: ~$43.50 stock price, ~$3.1B market cap, 11.3x trailing P/E, $3.86 TTM EPS. 52-week range: $27.91–$49.34. The stock is 12% off its 52-week high on a day when S&P futures are up 0.7%.
What Marex Actually Does
3,282 employees. Founded in the UK, US-listed on Nasdaq since 2024. Five operating segments: Commodities (metals, agricultural products, energy futures), Financial Products (FX, fixed income, equity futures), Clearing, Prime Services, and Investment Solutions.
The dual-role model is what separates it from pure-play brokers. Marex acts as both agent and principal — it can execute your commodity trade and provide the liquidity for it, clearing through the same platform. For a hedge fund or commodity producer, that’s fewer counterparties, faster execution, one relationship. It’s why clearing revenue grew 10% to $136.7M in 2025 even as M&A integrations were running in parallel — clients stick.
CEO Ian Lowitt on Q4: “This included growing engagement with larger clients, which reflects our strengthening competitive position.” That line matters. Marex has been moving upmarket — from mid-tier trading firms toward institutional clients with larger notional volumes per transaction. Prime Services is scaling fast as a result.
The latest acquisition: Webb Traders in March 2026, adding equity derivatives trading capability. It’s part of a multi-year M&A strategy that has expanded the platform without blowing margins — FY 2025 adjusted PBT margin actually expanded 60 basis points year-over-year despite multiple integrations running simultaneously. Most financial services companies see margin compression during integration phases.
Bull Case
The Q1 2026 guidance acceleration is the biggest tell. $667M–$697M in Q1 is a sequential step up from Q4 2025’s already-record $572M. Revenue is not normalizing — it’s accelerating. The market is treating this like a one-time volatility windfall. The guidance suggests it isn’t.
At 11x trailing earnings, Marex is priced like a static business. Comparable US financial services platform companies — clearing brokers, multi-asset market makers — typically trade at 15–20x earnings when they’re growing at this rate. A re-rating to just 15x on the current EPS run-rate gets you above $60 without needing the full TD Cowen $66 target to materialize.
Commodity market volatility has structural duration. Even if the Iran war ends in the next quarter (markets are pricing ceasefire optimism this morning), energy transition dynamics, supply chain rewiring, and geopolitical fragmentation keep commodity volatility elevated for years. The helium supply shock, the lithium recovery, the oil price swings — these aren’t temporary conditions. They’re the new normal for commodity markets, and Marex’s business model is built to profit from all of them.
YTD return for MRX: +13.89% versus the S&P 500’s +7.33%. 3-year total return: 123% versus 57% for the index. This stock has been quietly crushing the market and almost no one is talking about it.
Bear Case
Marex’s revenue is correlated with market activity. A clean resolution to the Iran war, a sharp drop in energy prices, and a return to 2023-style commodity market calm would take real revenue out of the model. The business wouldn’t collapse — it has grown through every market cycle for 11 years — but the Q1-style 43% revenue jumps would compress fast.
The Q1 guidance has now set an elevated bar. Analyst consensus for Q2 2026 is already pricing in a step down to around $529M in revenue, versus Q1’s guided $682M midpoint. If the market expects Q1 run-rates to continue and they don’t, there’s a correction risk even if Q2 numbers would be considered “good” in any prior year context.
Electronic competition is the slow-moving structural risk. Automated trading platforms continue to commoditize execution in some of the same markets Marex serves. Fee pressure is real, it’s just gradual. Management has managed it so far by expanding into higher-margin clearing and prime services — but it requires continuous reinvestment.
Integration risk from the acquisition pace is also real. Webb Traders, and the deals before it, have to be absorbed without disrupting the client relationships that drive clearing revenue. Management’s track record here is good, but the calendar is packed.
One more: Zacks revised the consensus Q2 EPS estimate 2% lower over the last 30 days (as of late March). Not alarming — it likely reflects the comps difficulty from Q1’s exceptional results — but worth tracking.
Verdict
Buy it if you think commodity volatility has legs and you want the infrastructure layer rather than the underlying commodities themselves. Marex is the toll booth, not the oil well. When producers like Ring Energy (REI) make more money at $101 oil, Marex makes more money on every barrel they hedge. It’s a cleaner expression of the same macro thesis with 11 years of unbroken profit growth backing it up.
The upside path: strong Q1 delivery in May, Prime Services continues scaling, market re-rates MRX toward 15x earnings. Target: $57–$66. The downside path: volatility normalizes faster than expected, Q2 revenue disappoints against the now-elevated bar, stock pulls back toward $35–$38. Even in that scenario, you’re buying a profitable platform at under 10x earnings.
Compelling at $43. Gets interesting at anything under $40 if the market pulls back. Worth a position for retail investors who follow commodity markets — which, right now, is everyone who reads financial news.
If you’re building out a commodity market exposure thesis, see our analysis of small-cap energy stocks as Brent hits $107 and the helium supply shock plays — both are feeding the same elevated-volatility environment that is driving Marex’s revenue surge.
This is not financial advice. Do your own research. I hold no position in MRX.
Key Stats
| Metric | Value |
|---|---|
| Ticker | MRX (Nasdaq) |
| Price (April 1, 2026) | ~$43.50 |
| Market Cap | ~$3.1B |
| P/E (TTM) | 11.3x |
| EPS (TTM) | $3.86 |
| FY 2025 Revenue | $2,024.1M (+27%) |
| FY 2025 Adj. PBT | $418.1M (+30%) |
| Q1 2026 Guided Revenue | $667M–$697M (+43–49% YoY) |
| Q1 2026 Guided Adj. PBT | $140M–$150M (+46–56% YoY) |
| 52-Week Range | $27.91–$49.34 |
| Avg. Analyst Target | $53.86 |
| TD Cowen Target | $66 (Buy, raised 3/27/26) |
| Dividend | $0.60/share (1.4%) |
| YTD Return | +13.89% vs S&P +7.33% |
| 3-Year Return | +123% vs S&P +57% |